Equities analysts expect Molina Healthcare, Inc. (NYSE:MOH) to report $4.96 billion in sales for the current quarter, according to Zacks. Six analysts have made estimates for Molina Healthcare’s earnings. The lowest sales estimate is $4.69 billion and the highest is $5.13 billion. Molina Healthcare reported sales of $4.46 billion in the same quarter last year, which would suggest a positive year over year growth rate of 11.2%. The firm is scheduled to issue its next quarterly earnings results on Wednesday, February 21st.

According to Zacks, analysts expect that Molina Healthcare will report full-year sales of $4.96 billion for the current year, with estimates ranging from $19.54 billion to $20.07 billion. For the next year, analysts expect that the firm will post sales of $20.19 billion per share, with estimates ranging from $18.43 billion to $21.06 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Molina Healthcare.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The firm had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $4.95 billion. During the same quarter in the prior year, the firm earned $0.85 EPS. The company’s revenue was up 10.7% compared to the same quarter last year.

Several research firms have weighed in on MOH. JPMorgan Chase & Co. raised Molina Healthcare from a “neutral” rating to an “overweight” rating in a research report on Tuesday. Leerink Swann upped their price target on Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, January 9th. Goldman Sachs Group started coverage on Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price target on the stock. Zacks Investment Research raised Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price target on the stock in a research report on Tuesday, January 2nd. Finally, Raymond James Financial reiterated a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $70.86.

In other Molina Healthcare news, Director John C. Molina sold 23,993 shares of the stock in a transaction that occurred on Wednesday, October 18th. The stock was sold at an average price of $62.55, for a total value of $1,500,762.15. Following the completion of the sale, the director now owns 517,529 shares in the company, valued at approximately $32,371,438.95. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Terry Bayer sold 9,077 shares of the stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $77.45, for a total value of $703,013.65. Following the completion of the sale, the chief operating officer now owns 74,478 shares of the company’s stock, valued at approximately $5,768,321.10. The disclosure for this sale can be found here. Insiders have sold a total of 634,445 shares of company stock valued at $47,201,288 over the last 90 days. 6.20% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the company. Zions Bancorporation bought a new position in Molina Healthcare during the 3rd quarter valued at approximately $118,000. Tiedemann Wealth Management LLC increased its holdings in shares of Molina Healthcare by 7.8% in the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after purchasing an additional 103,775 shares during the last quarter. Riverhead Capital Management LLC increased its holdings in shares of Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock worth $170,000 after purchasing an additional 963 shares during the last quarter. Sabal Trust CO bought a new stake in shares of Molina Healthcare in the third quarter worth about $206,000. Finally, Capstone Investment Advisors Netherlands B.V. bought a new stake in Molina Healthcare during the second quarter worth approximately $249,000.

Molina Healthcare (NYSE:MOH) traded up $3.76 during mid-day trading on Tuesday, reaching $89.58. The company’s stock had a trading volume of 1,208,906 shares, compared to its average volume of 1,293,122. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. Molina Healthcare has a twelve month low of $42.56 and a twelve month high of $86.39. The stock has a market capitalization of $5,180.00, a PE ratio of -17.00, a P/E/G ratio of 1.13 and a beta of 0.97.

WARNING: “Zacks: Brokerages Expect Molina Healthcare, Inc. (MOH) Will Announce Quarterly Sales of $4.96 Billion” was published by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/01/16/zacks-brokerages-expect-molina-healthcare-inc-moh-will-announce-quarterly-sales-of-4-96-billion.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.